Immunohistochemical assessment of Ki67 with antibodies SP6 and MIB1 in primary breast cancer: a comparison of prognostic value and reproducibility.
Research output: Contribution to journal › Article
To compare the antibodies, SP6 and MIB1, for assessment of Ki67 in primary breast cancer, regarding prognostic value and reproducibility.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Publication status||Published - 2014|
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Cancer Epidemiology (013007100), Pathology, (Lund) (013030000), Oncology, MV (013035000)
Related research output
Prognostic and Predictive Markers in Primary Breast Cancer - Quality Assurance and Long-term Effects of Adjuvant tamoxifen TreatmentMaria Ekholm, 2018, Lund: Lund University, Faculty of Medicine. 138 p.
Research output: Thesis › Doctoral Thesis (compilation)